Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2019

Open Access 01-12-2019 | Chronic Obstructive Lung Disease | Research

Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study

Authors: María Merino, Renata Villoro, Álvaro Hidalgo-Vega, Concepción Carmona, Collaborative Working Group EPOC-Extremadura

Published in: Health and Quality of Life Outcomes | Issue 1/2019

Login to get access

Abstract

Background

COPD is a high prevalence chronic disease that involves large reductions of health-related quality of life (HRQL) of patients. This study aims to describe the HRQL of patients with COPD in Extremadura (Spain).

Methods

This is a cross-sectional observational study carried out using a representative sample of patients diagnosed with COPD in Extremadura. The inclusion criteria were patients of legal age, diagnosed with COPD at least 12 months prior to the visit, residing in Extremadura, with electronic medical records available for the 12 months prior to the visit and providing informed consent. The intervention aimed to elicit HRQL indicators obtained from two validated questionnaires: EuroQol - 5 Dimensions - 5 Levels (EQ-5D-5L), and St. George’s Respiratory Questionnaire-COPD (SGRQ-C). The main outcome measures were general HRQL (utility and visual analogue scale) and specific quality of life of COPD patients (total score and three component scores: Symptoms, Activity, and Impacts). Stepwise multiple regression analysis was applied to evaluate the association of EQ-5D-5L and SGRQ-C with respect to clinical and sociodemographic characteristics of the patients.

Results

We recruited 386 patients (mean age 71.8 ± 10.3 years, 76.2% males). In the EQ-5D-5L, participants reported greater problems with respect to mobility (56.5%) and pain/discomfort (48.2%). The mean utility was 0.72 ± 0.31, and the SGRQ-C total score was 40.9 ± 25.0. The results of both questionnaires were associated with number of exacerbations in the last 12 months, level of COPD severity, gender, and education level of the patient (p < 0.05).

Conclusions

The results for both utility and total SGRQ-C score indicate that having suffered exacerbations in the last year, presenting a higher level of severity, being a woman, and having a low education level are related to worse HRQL in patients with COPD.
Literature
1.
go back to reference Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Guía española de la EPOC (GesEPOC) 2017. Tratamiento farmacológico de la EPOC estable. Arch Bronconeumol. 2017;53:324–35.PubMed Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Guía española de la EPOC (GesEPOC) 2017. Tratamiento farmacológico de la EPOC estable. Arch Bronconeumol. 2017;53:324–35.PubMed
2.
go back to reference Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863–8.CrossRef Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863–8.CrossRef
3.
go back to reference Sobradillo Peña V, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118:981–9.CrossRef Sobradillo Peña V, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118:981–9.CrossRef
5.
go back to reference Hidalgo Sierra V, Hernández Mezquita MÁ, Palomo Cobos L, García Sánchez M, Diego Castellanos R, Jodra Sánchez S, et al. Utilidad del dispositivo portátil Piko-6 para la detección precoz de la enfermedad pulmonar obstructiva crónica en atención primaria. Arch Bronconeumol. 2018;54:460–6.CrossRef Hidalgo Sierra V, Hernández Mezquita MÁ, Palomo Cobos L, García Sánchez M, Diego Castellanos R, Jodra Sánchez S, et al. Utilidad del dispositivo portátil Piko-6 para la detección precoz de la enfermedad pulmonar obstructiva crónica en atención primaria. Arch Bronconeumol. 2018;54:460–6.CrossRef
8.
go back to reference Pedone C, Giua R, Scichilone N, Bellia V, Antonelli-Incalzi R. GOLD staging system is appropriate to predict mortality in older people with chronic obstructive pulmonary disease. Arch Bronconeumol. 2018;54(7):365–70.CrossRef Pedone C, Giua R, Scichilone N, Bellia V, Antonelli-Incalzi R. GOLD staging system is appropriate to predict mortality in older people with chronic obstructive pulmonary disease. Arch Bronconeumol. 2018;54(7):365–70.CrossRef
9.
go back to reference Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, et al. Costes de la EPOC en España. Estimación a partir de un estudio epidemiológico poblacional. Arch Bronconeumol. 2004;40:72–9.PubMed Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, et al. Costes de la EPOC en España. Estimación a partir de un estudio epidemiológico poblacional. Arch Bronconeumol. 2004;40:72–9.PubMed
10.
go back to reference Espinosa Mesa N, Perea Herrera R, Vega García SS, Bermejo Guillén G, Lahoz Rallo B. Calidad de vida y situación sociosanitaria de los pacientes con EPOC. Med Fam. 2005;6:137–44. Espinosa Mesa N, Perea Herrera R, Vega García SS, Bermejo Guillén G, Lahoz Rallo B. Calidad de vida y situación sociosanitaria de los pacientes con EPOC. Med Fam. 2005;6:137–44.
11.
go back to reference Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003;123:784–91.CrossRef Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003;123:784–91.CrossRef
12.
go back to reference Dubé B-P, Vermeulen F, Laveneziana P. Exertional dyspnoea in chronic respiratory diseases: from physiology to clinical application. Arch Bronconeumol. 2017;53:62–70.CrossRef Dubé B-P, Vermeulen F, Laveneziana P. Exertional dyspnoea in chronic respiratory diseases: from physiology to clinical application. Arch Bronconeumol. 2017;53:62–70.CrossRef
13.
go back to reference Rubio MC, Hermosa JL, Soler-Cataluña JJ, López-Campos JL, Navarrete BA, Soriano JB, et al. Medical care according to risk level and adaptation to Spanish COPD guidelines (Gesepoc): the Epoconsul study. Arch Bronconeumol. 2018;54:270–9. Rubio MC, Hermosa JL, Soler-Cataluña JJ, López-Campos JL, Navarrete BA, Soriano JB, et al. Medical care according to risk level and adaptation to Spanish COPD guidelines (Gesepoc): the Epoconsul study. Arch Bronconeumol. 2018;54:270–9.
14.
go back to reference Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56:880–7 Accessed 19 Oct 2017.CrossRef Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56:880–7 Accessed 19 Oct 2017.CrossRef
15.
go back to reference Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31:416–69.CrossRef Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31:416–69.CrossRef
16.
go back to reference Daudey L, Peters JB, Molema J, Dekhuijzen PR, Prins JB, Heijdra YF, et al. Health status in COPD cannot be measured by the St George’s respiratory questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res. 2010;11:98.CrossRef Daudey L, Peters JB, Molema J, Dekhuijzen PR, Prins JB, Heijdra YF, et al. Health status in COPD cannot be measured by the St George’s respiratory questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res. 2010;11:98.CrossRef
17.
go back to reference Merino M, Villoro R, Hidalgo-Vega A, Carmona C. Collaborative working group EPOC-Extremadura. Social economic costs of chronic obstructive pulmonary disease in Extremadura (Spain): an observational study. Int J Chron Obstruct Pulmon Dis. 2018;13:2501–14.CrossRef Merino M, Villoro R, Hidalgo-Vega A, Carmona C. Collaborative working group EPOC-Extremadura. Social economic costs of chronic obstructive pulmonary disease in Extremadura (Spain): an observational study. Int J Chron Obstruct Pulmon Dis. 2018;13:2501–14.CrossRef
19.
go back to reference Garcia-Gordillo MA, Adsuar JC, Olivares PR. Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish health survey, 2011. Qual Life Res. 2016;25(5):1313–21.CrossRef Garcia-Gordillo MA, Adsuar JC, Olivares PR. Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish health survey, 2011. Qual Life Res. 2016;25(5):1313–21.CrossRef
21.
go back to reference Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest. 2007;132:456–63.CrossRef Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest. 2007;132:456–63.CrossRef
22.
go back to reference Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodríguez E, Benet M, et al. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulm Med. 2015;15:4.CrossRef Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodríguez E, Benet M, et al. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulm Med. 2015;15:4.CrossRef
23.
go back to reference Jones PW, Brusselle G, Negro RWD, Ferrer M, Kardos P, Levy ML, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105:57–66.CrossRef Jones PW, Brusselle G, Negro RWD, Ferrer M, Kardos P, Levy ML, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105:57–66.CrossRef
24.
go back to reference Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16:70.CrossRef Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16:70.CrossRef
25.
go back to reference Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013;107:233–41.CrossRef Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013;107:233–41.CrossRef
26.
go back to reference von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in COPD. Eur Respir J. 2011;38:p3638. von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in COPD. Eur Respir J. 2011;38:p3638.
27.
go back to reference Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD. Chest. 2008;134:43S–56S.CrossRef Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD. Chest. 2008;134:43S–56S.CrossRef
28.
go back to reference Miravitlles M, Huerta A, Valle M, García-Sidro P, Forné C, Crespo C, et al. Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:367–77.CrossRef Miravitlles M, Huerta A, Valle M, García-Sidro P, Forné C, Crespo C, et al. Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:367–77.CrossRef
29.
go back to reference Miravitlles M, Huerta A, Fernández-Villar JA, Alcázar B, Villa G, Forné C, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014;12:120.CrossRef Miravitlles M, Huerta A, Fernández-Villar JA, Alcázar B, Villa G, Forné C, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014;12:120.CrossRef
31.
go back to reference Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respir Int Rev Thorac Dis. 2011;82:402–8. Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respir Int Rev Thorac Dis. 2011;82:402–8.
32.
go back to reference Kurpas D, Szwamel K, Mroczek B. The Environmental Domain of Quality of Life in Patients with Chronic Respiratory Diseases. Adv Exp Med Biol. 2016;905:5–16.CrossRef Kurpas D, Szwamel K, Mroczek B. The Environmental Domain of Quality of Life in Patients with Chronic Respiratory Diseases. Adv Exp Med Biol. 2016;905:5–16.CrossRef
33.
go back to reference Toledo-Pons N, Cosío BG, Velasco MV, Casanova C. Enfermedad pulmonar obstructiva crónica de origen no tabáquico. Arch Bronconeumol. 2017;53:45–6.PubMed Toledo-Pons N, Cosío BG, Velasco MV, Casanova C. Enfermedad pulmonar obstructiva crónica de origen no tabáquico. Arch Bronconeumol. 2017;53:45–6.PubMed
Metadata
Title
Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study
Authors
María Merino
Renata Villoro
Álvaro Hidalgo-Vega
Concepción Carmona
Collaborative Working Group EPOC-Extremadura
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2019
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-019-1244-4

Other articles of this Issue 1/2019

Health and Quality of Life Outcomes 1/2019 Go to the issue